Literature DB >> 20354905

Does the geographical gradient of ApoE4 allele exist in China? A systemic comparison among multiple Chinese populations.

Peng Hu1, Yuan Han Qin, Cheng Xue Jing, Ling Lu, Bo Hu, Peng Fei Du.   

Abstract

The allelic frequencies of apolipoprotein E (apoE) vary substantially around the world. There is a conspicuous south-to-north gradient of e4 frequencies in Europe, with the proportion of e4 carriers from only 10-15% in the south to 40-50% in the north. The mechanism may be related to the possibility that e4 carriers are less likely to develop vitamin D deficiency. In addition, Asian populations traditionally have lower e4 frequency than Europeans, which may be attributed in part to the scarce or irregular food supplies in Western world in the recent past. However, whether these geographical distribution gradients exist in China is yet unknown. ApoE genotypes of 200 children from Nanning City were determined by PCR-restriction fragment length polymorphism (RFLP) analysis. Allele frequency data of 18 other populations were collected from published sources and correlated with latitude and longitude information from different geographic resources. In our subjects, the frequencies of apoE genotypes were E3/E3: 73.0%, E3/E2: 15.0%, E4/E3: 5.0%, E4/E4: 5.0%, and E4/E2: 2.0%; the frequencies of apoE alleles were e2: 8.5%, e3: 83.0%, and e4: 8.5%, respectively. The total sample consisted of 3,679 individuals from 19 Chinese populations; the allelic frequencies were e2: 7.6%, e3: 85.5%, and e4: 6.9%, respectively; the proportion of e4 carriers was from 4.9% in Kunming to 17.5% in Harbin. Systemic comparison among multiple Chinese populations revealed that positive correlation existed between the e4 allele frequency distribution and latitude north (r=0.586, P=0.008), but no correlation of the e4 allele frequency distribution with longitude east was found (r=-0.018, P=0.942). We conclude that there is a south-to-north, but not an east-to-west gradient for the apoE4 allele in China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354905     DOI: 10.1007/s11033-010-0132-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  42 in total

1.  APOE distribution in world populations with new data from India and the UK.

Authors:  P P Singh; M Singh; S S Mastana
Journal:  Ann Hum Biol       Date:  2006 May-Jun       Impact factor: 1.533

2.  Bone health, genetics, and personalised nutrition.

Authors:  Kevin D Cashman; Kelly Seamans
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

3.  Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population.

Authors:  Rami A R Mahfouz; Amira S Sabbagh; Laila F Zahed; Ziyad R Mahfoud; Rana F Kalmoni; Zaher K Otrock; Ali T Taher; Ghazi S Zaatari
Journal:  Mol Biol Rep       Date:  2006-06       Impact factor: 2.316

4.  Association of apolipoprotein E gene polymorphism with essential hypertension and its complications.

Authors:  Xiaotao Li; Yanmei Du; Yanfang Du; Xizheng Huang
Journal:  Clin Exp Med       Date:  2003-02       Impact factor: 3.984

5.  The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese.

Authors:  Samuel Yeung Shan Wong; Edith Ming Chu Lau; Martin Li; Tiffany Chung; Aprille Sham; Jean Woo
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Effect of apolipoprotein E genotype on vitamin K status in healthy older adults from China and the UK.

Authors:  Liya Yan; Bo Zhou; Shailja Nigdikar; Xiaohong Wang; Janet Bennett; Ann Prentice
Journal:  Br J Nutr       Date:  2005-12       Impact factor: 3.718

7.  Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters.

Authors:  Shu Liang; Min Pan; Hai-Hua Geng; Hui Chen; Li-Qun Gu; Xiao-Tong Qin; Jin-Jun Qian; Jian-Hua Zhu; Chun-Feng Liu
Journal:  Mol Biol Rep       Date:  2008-07-04       Impact factor: 2.316

8.  Influence of polymorphisms for apolipoprotein B (ins/del, XbaI, EcoRI) and apolipoprotein E on serum lipids and apolipoproteins in a Javanese population.

Authors:  B Gajra; J K Candlish; N Saha; C K Heng; A G Soemantri; J S Tay
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

9.  Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes.

Authors:  Yun Yue; Ling Hu; Qin-jie Tian; Jing-mei Jiang; Yi-long Dong; Zheng-yu Jin; Yu-hang Cheng; Xia Hong; Qin-sheng Ge; Ping-ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2007-08       Impact factor: 6.150

10.  Analysis of the association between apolipoprotein E polymorphism and cardiovascular risk factors in an elderly population with longevity.

Authors:  Carla Helena Augustin Schwanke; Ivana Beatrice Mânica da Cruz; Ney Furhmann Leal; Rosane Scheibe; Yukio Moriguchi; Emílio Hideyuki Moriguchi
Journal:  Arq Bras Cardiol       Date:  2002-06       Impact factor: 2.000

View more
  19 in total

Review 1.  A Quarter Century of APOE and Alzheimer's Disease: Progress to Date and the Path Forward.

Authors:  Michaël E Belloy; Valerio Napolioni; Michael D Greicius
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

2.  Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Authors:  D D V Brito; A P Fernandes; K B Gomes; F F Coelho; N G Cruz; A P Sabino; J E Cardoso; P P Figueiredo-Filho; R Diamante; C R Norton; M O Sousa
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

3.  Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Hui-Ling Xu
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

4.  The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia.

Authors:  Cong Cai; Zhongzheng Wen; Linrui Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Clinical application of whole-exome sequencing: A retrospective, single-center study.

Authors:  Qiang Zhang; Zailong Qin; Shang Yi; Hao Wei; Xun Zhao Zhou; Jiasun Su
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

6.  TOMM40 and APOE variants synergistically increase the risk of Alzheimer's disease in a Chinese population.

Authors:  Zheng Zhu; Yang Yang; Zhenxu Xiao; Qianhua Zhao; Wanqing Wu; Xiaoniu Liang; Jianfeng Luo; Yang Cao; Minhua Shao; Qihao Guo; Ding Ding
Journal:  Aging Clin Exp Res       Date:  2020-07-28       Impact factor: 3.636

7.  ApoE polymorphism may determine low-density lipoprotein cholesterol level in association with obesity and metabolic syndrome in postmenopausal Korean women.

Authors:  Duck-Joo Lee; Kwang-Min Kim; Bom-Taeck Kim; Kyu-Nam Kim; Nam-Seok Joo
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

8.  Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children.

Authors:  Peng Hu; Yuan Han Qin; Feng Ying Lei; Juan Pei; Bo Hu; Ling Lu
Journal:  Int J Mol Sci       Date:  2011-08-31       Impact factor: 5.923

Review 9.  The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity.

Authors:  Paolo Abondio; Marco Sazzini; Paolo Garagnani; Alessio Boattini; Daniela Monti; Claudio Franceschi; Donata Luiselli; Cristina Giuliani
Journal:  Genes (Basel)       Date:  2019-03-15       Impact factor: 4.096

10.  Apolipoprotein E genotyping using PCR-GoldMag lateral flow assay and its clinical applications.

Authors:  Ting Lian; Wenli Hui; Xianying Li; Chao Zhang; Juanli Zhu; Rui Li; Yinsheng Wan; Yali Cui
Journal:  Mol Med Rep       Date:  2016-09-23       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.